Article
ATXN7 Gene Variants and Expression Predict Post-Operative Clinical Outcomes in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology - 1 Jan 2016
Han Chuangye, Yu Long, Liu Xiaoguang, Yu Tingdong, Qin Wei, Liao Xiwen, Liu Zhengtao, Lu Sicong, Chen Zhiwei, Su Hao, Zhu Guangzhi, Qin Xue, Gui Ying, Li Jiaquan, Xiao Kaiyin, Chen Xigang, Ye Xinping, Peng Minhao, Dong Jiahong, Peng Tao
Abstract excerpt
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is a lethal disease with nearly equal morbidity and mortality. Thus, the discovery and application of more useful predictive biomarkers for improving therapeutic effects and prediction of clinical outcomes is of crucial significance. METHODS: A total of 475 HBV-related HCC patients were enrolled. Ataxin 7 (ATXN7) single nucleotide polymorphisms (SNPs) were genotyped...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
